Certara, Inc. operates as a bio-technology company. The Company focuses on accelerating medicines to patients using biosimulation software and technology to transform traditional drug discovery and development. Certara serves customers worldwide.

Annual Report (Amendment) (Form 10-K/A | Period ending 2023-12-31)

Quarterly Report (Form 10-Q | Period ending 2024-09-30)

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Certara (CERT US)

Annual Report (Amendment) (Form 10-K/A | Period ending 2023-12-31)

Quarterly Report (Form 10-Q | Period ending 2024-09-30)

Current Report (Form 8-K | Period ending 2024-11-06)

Current Report (Form 8-K | Period ending 2024-10-16)

Current Report (Form 8-K | Period ending 2024-08-06)

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)